V012-1576 Screening compound: 2-[(4-methylphenoxy)methyl]-N-[2-(3,5,5-trimethylhexanamido)cyclohexyl]-1,3-thiazole-4-carboxamide

V012-1576 Screening compound: 2-[(4-methylphenoxy)methyl]-N-[2-(3,5,5-trimethylhexanamido)cyclohexyl]-1,3-thiazole-4-carboxamide
V012-1576 Screening compound: 2-[(4-methylphenoxy)methyl]-N-[2-(3,5,5-trimethylhexanamido)cyclohexyl]-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-1576
2-[(4-methylphenoxy)methyl]-N-[2-(3,5,5-trimethylhexanamido)cyclohexyl]-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-1576

Molecular Formula

C27H39N3O3S (C27 H39 N3 O3 S)

Compound Name

2-[(4-methylphenoxy)methyl]-N-[2-(3,5,5-trimethylhexanamido)cyclohexyl]-1,3-thiazole-4-carboxamide

IUPAC name

2-[(4-methylphenoxy)methyl]-N-[2-(355-trimethylhexanamido)cyclohexyl]-13-thiazole-4-carboxamide

SMILES

CC(CC(C)(C)C)CC(NC(CCCC1)C1NC(c1csc(COc2ccc(C)cc2)n1)=O)=O

InChI

InChI=1S/C27H39N3O3S/c1-18-10-12-20(13-11-18)33-16-25-29-23(17-34-25)26(32)30-22-9-7-6-8-21(22)28-24(31)14-19(2)15-27(3,4)5/h10-13,17,19,21-22H,6-9,14-16H2,1-5H3,(H,28,31)(H,30,32)

InChI Key

REVRCDJOKKYODF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19967998

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.69

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.229

Distribution Coefficient, logD

6.229

Water Solubility, LogSw

-5.40

Polar Surface Area

66.890

Acid Dissociation Constant (pKa)

15.11

Base Dissociation Constant (pKb)

-0.17

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

59.30

V012-1576 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V012-1576 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-1576?
Check Price and Availability of V012-1576, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-1576 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-1576
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-1576
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-1576 available by request